Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways

Last updated: January 5, 2022
Sponsor: Rijnstate Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05181111
LHC 2021-1838
  • Ages > 18
  • All Genders

Study Summary

Hospitals aim to hospitalize patients when necessary and discharge patients when possible. However, the triage process and discharge management of patients in e.g. the Acute Admission Ward, is not a trivial task. The upcoming technology of wearable monitoring devices, whereby patients can be continuously monitored with an unobtrusive vital signs device, might help getting more insight into patients' health condition and thus help facilitate efficient and effective triaging.

Therefore, the primary objective is to assess the effects of continuous monitoring of patients in the acute admission ward (AAW) on the percentage of patients who can be discharged home. Secondary objectives are to assess the length of stay in the acute admission ward and in the in-hospital wards, as well as the effect on admission to the intensive care unit, rapid response team calls and hospital readmission. The predictive value of algorithms applied to the monitoring data combined with other parameters to detect timely deterioration and predict discharge will be assessed. Facilitators and barriers for implementing such a system will be investigated.

Eligibility Criteria

Inclusion

Inclusion Criteria: In order for a patient to be eligible to participate in this study, the following criterianeed to be met:

  • admitted to the AAW
  • Age ≥ 18 years
  • Able to speak and read Dutch
  • Willing and able to provide written informed consent

Exclusion

Exclusion Criteria: A patient who meets any of the following criteria will be excluded from participation:

  • Not able or willing to wear a wearable sensor on the chest continuously for 14 days
  • Planned major surgery in the upcoming 30 days
  • At the time of AAW admission already known to be discharged home or admitted to thehospital
  • Any skin condition, for example prior rash, discoloration, scars, infection, injury oropen wounds at the area (Left lower rib) where the sensor needs to be placed
  • Known sensitivity to medical adhesives
  • Wearing an active implantable device (e.g. ICD, pacemaker)
  • Intend to go to the sauna or go swimming in the upcoming 14 days
  • Pregnant or breastfeeding
  • Use of creams or lotions that are known to influence the skin at the area where sensoris placed (such as medical and non-medical creams or lotions)

Study Design

Total Participants: 800
Study Start date:
December 06, 2021
Estimated Completion Date:
July 01, 2023

Connect with a study center

  • Rijnstate Hospital

    Arnhem, 6800 TA
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.